Video captured the terrifying moment dozens of gunshots rang out outside the White House on Saturday night when an ABC News correspondent was seen diving for safety in the middle of a standup on the North Lawn.

Today's Key Events (All EST) — 10/28/2026 07:00: US MBA Mortgage Applications 08:30: US Trade Balance 14:00: FOMC Rate Statement 14:00: US FOMC Statement 14:30: Fed's Powell Press Conference Before Open 👇 05:55: Vertiv Holdings Co (VRT) 06:00: Generac Holdings (GNRC) 06:00: V.F. (VFC) 06:30: GE Vernova (GEV) 06:30: Boston Scientific (BSX) 06:30: HF Sinclair (DINO) 07:00: Phillips 66 (PSX) 07:00: Automatic Data Processing (ADP) 07:00: International Paper (IP) 07:05: Flex (FLEX) 08:00: Amphenol (APH) BMO: Biogen (BIIB) BMO: UBS Group AG (UBS) BMO: Etsy (ETSY) BMO: STLA, GPI, EDU, TEL, CSTM, SITE, AVTR, OTIS, GEHC, AON, NI, CPF, PB, SW, PSN, EVR, LII, EAT, OSW, STNG, LH, AEP, DAN, BLCO, PAG, OTLY, GRMN, IEX, MAS, KEX, LFUS, ODFL, OGE, TEX, UE, AER, AMRN, BLKB, CHEF, DBD, HAYW, SCL, SHEN, PUMP, IONS, AXGN, EXTR, UMC, CHRW, FTV, CLH, JLL, MGPI, PRG, FNMA, WING, HOPE, OSS, REPL, ULCC, FELE, JMSB, CFFN, FMX, DB, EQNR, GSK, JMKE After Hours 👇 16:00: Alphabet (GOOGL) 16:00: T-Mobile US (TMUS) 16:00: FormFactor (FORM) 16:05: Microsoft (MSFT) 16:05: KLA (KLAC) 16:05: Carvana (CVNA) 16:05: Fortinet (FTNT) 16:05: FedEx (FDX) 16:05: Tenable Holdings (TENB) 16:10: ServiceNow (NOW) 16:10: Chipotle Mexican Grill (CMG) 16:30: O'Reilly Automotive (ORLY) 17:00: Alphabet (GOOG) AMC: MRAM, SFM, VNDA, CHDN, COHU, MGRC, PRCH, EBAY, F, VKTX, ARXS, HAPN, STRL, NEO, BHE, CCS, GEN, GKOS, HONA, LENZ, TDOC, ADAM, ALKT, AMSF, BHC, CMPR, CNMD, CNXN, CSL, EFOR, EQIX, FLS, MAX, MDXG, NEWT, NXT, OLED, OPK, PBI, SPOK, T.CP, BOOT, FPI, JBSS, LARK, LXU, THG, UFPI, PI, AR, AUR, GBFH, GFL, HLI, KREF, MGM, TYL, VICI, AM, AXS, BNL, CBAN, CYH, EG, EIG, EPR, FINW, HRTG, ILPT, INVH, MAA, MYRG, NWPX, OBK, PLXS, QTWO, RJF, RSI, SCI, UVSP, EHC, FCPT, MTH, MUSA, QUAD, ALRS, AWK, CP, NNBR, PFS, ALGN, MKL, RYZ, AMRZ, WEX, AEM, KGC, AGI, EGO, PPC, WFG, WHD, CLB, FBRT, ASTL, SIMO, EPAC, VIST

Premarket movers Meta shares outperform Magnificent 7 peers, with the cohort helping boost stock futures: Meta Platforms (META) +1.6%, Microsoft (MSFT) +0.4%, Alphabet (GOOGL) -0.2%, Amazon (AMZN) -0.2%, Apple (AAPL) +0.2%, Nvidia (NVDA) -0.2%, Tesla (TSLA) little changed Adobe (ADBE) slips 2.6% after Wells Fargo Securities downgraded the maker of software for creative professionals by two notches to underweight. AST SpaceMobile (ASTS) rises 4.4% after Deutsche Bank upgraded the satellite broadband operator to buy, seeing a buying opportunity in the wake of recent weakness. Biogen (BIIB) gains 4.1% as JPMorgan upgrades to overweight ahead of an increasingly compelling catalyst path in 2027. Bristol Myers (BMY) rises 4.4% after the drugmaker said a late-stage trial of a lower dose of its drug candidate for lung disease met its primary endpoint. CCC Intelligent Solutions (CCC) rises 11% as GTCR and Elliott Investment Management are said to be in advanced talks to acquire the car-insurance software provider. First Solar (FSLR) climbs 2.7% after Truist Securities upgraded the alternative energy company to buy, seeing “a stronger backdrop for pricing into the 2030s.” First Tracks Biotherapeutics (TRAX) gains 16% after the drug developer gave topline results from an early-stage trial of its experimental therapy for celiac disease. Hub Group (HUBG) gains 3.8% after Baird analyst Daniel Moore raised the recommendation on the transportation company to outperform, writing that the stock’s risk-reward profile has grown increasingly attractive. Iren (IREN) rises 3.8% as the Information reports that the crypto miner-turned-AI server provider has entered a multiyear cloud deal with Anthropic. Manhattan Associates (MANH) rises 3.5% after Morgan Stanley upgraded the software company to overweight, seeing it as a potential AI winner. Salesforce (CRM) climbs 4.1% after BofA Global Research raised the recommendation on the software company to buy, pointing to tailwinds from AI adoption. Tyler Technologies (TYL) gains 2.5% after Wells Fargo Securities upgraded the software company to overweight from equal-weight, seeing fading headwinds.

$PGR（Progressive） 5.8.1 快照与技术选股归属：现价222.88，市值129.58B，52周区间189.2到239.38，现金及等价物138.0M，短期投资10005.0M，流动性合计10143.0M，季度经营现金流3607.0M为正，跑道不适用（经营现金流为正，不依赖现金消耗），年度财报12/31/2025收入87671.0M，净利润11308.0M，研发无M，资本支出-348.0M，季度财报6/30/2026收入23609.0M，净利润3311.0M，流动比率nan%，毛利率17.18%，营业利润率16.54%（数据来源：个股基本面快照，2026-10-14）；技术选股D组硬条件命中，分数58.55，获利盘93.15%，套牢盘6.85%，90%集中度6.92（数据来源：技术选股，2026-10-14）。 5.8.2 主营业务与产品技术亮点：Progressive是美国车险龙头，主营个人汽车保险、房屋保险与商业保险。核心技术亮点包括直接分销与代理人双渠道，基于驾驶行为的UBI定价技术，理赔数字化与快速结算能力。本条不写数字。 5.8.3 事件促发点：2026-10-14 Progressive发布财报，预期EPS为4.46，涉及季度业绩，量级判断重大，方向待定（数据来源：未来5日财报日历，2026-10-14）。暂无其他已公开促发点。 5.8.4 大行研报与消息汇总：目标价均值无，买入无，持有无，卖出无（数据来源：Nasdaq分析师库，2026-10-14）。Barclays目标价246上调至247，上调0.4%，头部国际大行，距现价16.4%（数据来源：MarketBeat 2026-10-07）；HSBC目标价221下调至216，下调-2.3%，非头部，距现价1.79%（数据来源：MarketBeat 2026-10-07）。消息面：Zacks对PGR发出混合展望（Foreign Policy Journal 2026-10-13）。 5.8.5 关键价位、触发与失效：日线支撑筹码峰206.04距现价8.17%，日线压力20日高223.78距现价0.4%，周线支撑周线MA10为216.7距现价2.77%，周线压力52周高239.38距现价7.4%（数据来源：个股筹码四元组与关键价位，2026-10-14）。触发条件为放量突破20日高223.78，失效条件为跌破筹码峰206.04。资金共振同向项数2项（数据来源：3.1节，2026-10-14）。 5.8.6 情景：牛档239.38（周线压力52周高），基准档223.78（日线压力20日高），熊档206.04（日线支撑筹码峰）。从现价到周线压力空间7.4%。 5.8.7 结论：等触发，1到2周期望幅度至223.78约0.4%，赔率中性，建议观察，最大风险是财报不及预期。第一目标223.78，第二目标239.38。 5.9 $BIIB（Biogen） 5.9.1 快照与技术选股归属：现价228.9，市值33.82B，52周区间138.0到238.24，现金及等价物3008.5M，短期投资807.2M，流动性合计3815.7M，季度经营现金流448.9M为正，跑道不适用（经营现金流为正，不依赖现金消耗），年度财报12/31/2025收入9890.6M，净利润1292.9M，研发1778.6M，资本支出-153.8M，季度财报6/30/2026收入2736.0M，净利润97.5M，流动比率267.9%，毛利率75.69%，营业利润率18.83%（数据来源：个股基本面快照，2026-10-14）；技术选股D组硬条件命中，分数38.68，获利盘97.73%，套牢盘2.27%，90%集中度11.81（数据来源：技术选股，2026-10-14）。 5.9.2 主营业务与产品技术亮点：Biogen是生物技术公司，主营多发性硬化、阿尔茨海默病与神经科学药物。核心技术亮点包括神经科学管线深度，阿尔茨海默病抗体药物，与Eisai等合作伙伴的全球商业化能力。本条不写数字。 5.9.3 事件促发点：2026-10-12 JPMorgan升级至Overweight，目标价210上调至300，涉及评级与目标价，量级判断重大，方向利多（数据来源：MarketBeat 2026-10-12）。暂无其他已公开促发点。 5.9.4 大行研报与消息汇总：目标价均值241.96，区间175.0到300.0，买入17家，持有6家，卖出1家，下期EPS预测12.41（Dec 2026），近4周EPS上修2家下修1家（数据来源：Nasdaq分析师库，2026-10-14）。JPMorgan升级至Overweight，目标价210上调至300，上调42.9%，头部五大，距现价32.91%（数据来源：MarketBeat 2026-10-12）；UBS目标价240上调至270，上调12.5%，头部国际大行，距现价21.7%（数据来源：MarketBeat 2026-10-09）；BMO目标价未披露至220，来源弱，非头部，距现价-5.12%（数据来源：MarketBeat 2026-10-12）。消息面：无。 5.9.5 关键价位、触发与失效：日线支撑筹码峰217.12距现价5.43%，日线压力20日高238.24距现价4.08%，周线支撑周线MA10为221.97距现价3.03%，周线压力52周高238.24距现价4.08%（数据来源：个股筹码四元组与关键价位，2026-10-14）。触发条件为放量突破20日高238.24，失效条件为跌破筹码峰217.12。资金共振同向项数3项（数据来源：3.1节，2026-10-14）。 5.9.6 情景：牛档238.24（周线压力52周高，与日线压力同位），基准档217.12（日线支撑筹码峰），熊档221.97（周线支撑周线MA10）。从现价到周线压力空间4.08%。 5.9.7 结论：可买，1到2周期望幅度至238.24约4.1%，赔率中性偏多，建议半仓，最大风险是神经科学药物竞争加剧。第一目标238.24，第二目标无更高参照，突破后重算。